Defining critical residues m the epitope for a hiv-neutralizing monoclonal antibody using phage display and peptide array technologies

Gene ◽  
1993 ◽  
Vol 137 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Cindy L. Jellis ◽  
Thomas J. Cradick ◽  
Paul Rennert ◽  
Paul Salinas ◽  
James Boyd ◽  
...  
2002 ◽  
Vol 76 (9) ◽  
pp. 4241-4250 ◽  
Author(s):  
M. Ostrowski ◽  
J. A. Galeota ◽  
A. M. Jar ◽  
K. B. Platt ◽  
F. A. Osorio ◽  
...  

ABSTRACT After infection of swine with porcine reproductive and respiratory syndrome virus (PRRSV), there is a rapid rise of PRRSV-specific nonneutralizing antibodies (NNA), while neutralizing antibodies (NA) are detectable not sooner than 3 weeks later. To characterize neutralizing epitopes, we selected phages from a 12-mer phage display library using anti-PRRSV neutralizing monoclonal antibody (MAb) ISU25-C1. In addition, phages carrying peptides recognized by swine antibodies with high seroneutralizing titer were isolated after subtracting from the library those clones binding to swine anti-PRRSV serum with no neutralizing activity. Two epitopes located in the ectodomain of PRRSV GP5 were identified. One of these epitopes, which we named epitope B, was recognized both by neutralizing MAb ISU25-C1 and swine neutralizing serum (NS) but not by swine nonneutralizing serum (NNS), indicating that it is a neutralizing epitope. Epitope B is sequential, conserved among isolates, and not immunodominant. Antibodies directed against it are detected in serum late after infection. In contrast, the other epitope, which we named epitope A, is hypervariable and immunodominant. Antibodies against it appear early after infection with PRRSV. This epitope is recognized by swine NNA but is not recognized by either neutralizing MAb ISU25-C1 or swine NA, indicating that it is not involved in PRRSV neutralization. During infection with PRRSV, epitope A may act as a decoy, eliciting most of the antibodies directed to GP5 and delaying the induction of NA against epitope B for at least 3 weeks. These results are relevant to the design of vaccines against PRRSV.


1993 ◽  
Vol 69 (03) ◽  
pp. 240-246 ◽  
Author(s):  
Midori Shima ◽  
Dorothea Scandella ◽  
Akira Yoshioka ◽  
Hiroaki Nakai ◽  
Ichiro Tanaka ◽  
...  

SummaryA neutralizing monoclonal antibody, NMC-VIII/5, recognizing the 72 kDa thrombin-proteolytic fragment of factor VIII light chain was obtained. Binding of the antibody to immobilized factor VIII (FVIII) was completely blocked by a light chain-specific human alloantibody, TK, which inhibits FVIII activity. Immunoblotting analysis with a panel of recombinant protein fragments of the C2 domain deleted from the amino-terminal or the carboxy-terminal ends demonstrated binding of NMC-VIII/5 to an epitope located between amino acid residues 2170 and 2327. On the other hand, the epitope of the inhibitor alloantibody, TK, was localized to 64 amino acid residues from 2248 to 2312 using the same recombinant fragments. NMC-VIII/5 and TK inhibited FVIII binding to immobilized von Willebrand factor (vWF). The IC50 of NMC-VIII/5 for the inhibition of binding to vWF was 0.23 μg/ml for IgG and 0.2 μg/ml for F(ab)'2. This concentration was 100-fold lower than that of a monoclonal antibody NMC-VIII/10 which recognizes the amino acid residues 1675 to 1684 within the amino-terminal portion of the light chain. The IC50 of TK was 11 μg/ml by IgG and 6.3 μg/ml by F(ab)'2. Furthermore, NMC-VIII/5 and TK also inhibited FVIII binding to immobilized phosphatidylserine. The IC50 for inhibition of phospholipid binding of NMC-VIII/5 and TK (anti-FVIII inhibitor titer of 300 Bethesda units/mg of IgG) was 10 μg/ml.


Virology ◽  
2012 ◽  
Vol 432 (2) ◽  
pp. 394-404
Author(s):  
Jasminka Sterjovski ◽  
Melissa J. Churchill ◽  
Anne Ellett ◽  
Steve L. Wesselingh ◽  
Paul A. Ramsland ◽  
...  

Virology ◽  
2012 ◽  
Vol 431 (1-2) ◽  
pp. 40-49 ◽  
Author(s):  
Dustin M. McCraw ◽  
Jason K. O’Donnell ◽  
Kenneth A. Taylor ◽  
Scott M. Stagg ◽  
Michael S. Chapman

Intervirology ◽  
1992 ◽  
Vol 34 (2) ◽  
pp. 86-93 ◽  
Author(s):  
Ranajit Pal ◽  
Fulvia di Marzo Veronese ◽  
B.C. Nair ◽  
Rukhsana Rahman ◽  
George Hoke ◽  
...  

2017 ◽  
Vol 22 (2) ◽  
pp. 114-119 ◽  
Author(s):  
Jun-Yeol Yoon ◽  
Dong-Hwan Kim ◽  
Sangkyu Kim ◽  
Dain Kim ◽  
Gyunghee Jo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document